Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin alone versus azithromycin + lactulose for acute purulent rhinosinusitis in children
ISRCTN14790675Phase 4Completed
- Sponsor
- AVVA RUS JSC
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of azithromycin and lactulose in acute purulent rhinosinusitis (APRS) (2 arms), sponsored by AVVA RUS JSC. Primary endpoints: Clinical improvement by day 4 and Bacterial rhinosinusitis symptom improvement. Started Apr 2015; status: completed.
02
Drugs
azithromycinlactulose
03
Conditions
acute purulent rhinosinusitis (APRS)
Beyond the preview
Go deeper on ISRCTN14790675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14790675.